COMMUNIQUÉS West-GlobeNewswire

Scilex Holding Company Announces New Out-of-Pocket Costs for Commercially Insured Patients
21/03/2024
PALO ALTO, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]
Sandoz opens new antibiotic production facility in Austria, to significantly increase capacity for life-saving medicines
21/03/2024
MEDIA RELEASE EUR 50m investment in Kundl plant extension emphasizes commitment to serve more patients with critical antibiotics, produced entirely in Europe Additional manufacturing area of 3,000m 2 means Kundl can now [...]
Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider
21/03/2024
Dallas, TX, March 21, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), a global leader in drug testing using hair analysis, is proud to announce its recognition as one of the Top 10 Employee Health [...]
Compass Therapeutics Reports 2023 Financial Results and Provides Corporate Update
21/03/2024
Enrollment in COMPANION-002, the Phase 2/3 randomized study of CTX-009 (DLL4 x VEGF-A bispecific antibody) in patients with advanced biliary tract cancer (BTC), continues to progress well; top-line data from this study [...]
Evn Introduces Innovative CBD+THC Ashwagandha Gummies for Optimal Stress Adaptation and Recovery
21/03/2024
NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- Evn , a leader in hemp-derived cannabinoid products, is excited to announce the launch of its new product, Ashwagandha Gummies infused with CBD and THC, aimed at aiding [...]
NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th
21/03/2024
Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., March 21, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over [...]
Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape
21/03/2024
-- CEO Kathy Lee-Sepsick and Chief Medical Officer James Liu to Join Jones Trading Analyst Catherine Novack in a Conversation on Current Treatment Options in Infertility Including FemaSeed® at 1PM ET -- ATLANTA, March [...]
SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research
21/03/2024
MitoCareX Bio dedicates efforts to creating a predictive AI model to predict small molecules more efficiently TEL AVIV, Israel, March 21, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), [...]
NextCure Provides Business Update and Reports Full Year 2023 Financial Results
21/03/2024
Prioritizing and focusing on highest-value opportunities NC410 (ovarian and CRC) and LNCB74 (B7-H4 ADC) Based on early evidence of clinical activity with NC410 combo, expanding ovarian and CRC cohorts with data updates [...]
United Health Products Submits Full FDA PMA Application
21/03/2024
MOUNT LAUREL, NJ, March 21, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s FDA Premarket Approval application process. The company [...]
LIXTE Provides Update on Progress with LB-100 as a PP2A Inhibitor to Enhance Chemotherapy and Immunotherapy Cancer Treatments
21/03/2024
-- Three Clinical Trials Currently Underway for Treating Ovarian, Lung and Sarcoma Cancers -- PASADENA, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc . (“LIXTE” or the “Company”) (Nasdaq: [...]
Rose Hill Partners with University of Guelph for Groundbreaking Study to Advance Research for the Potential Benefits of Psilocybin Mushrooms to Address Autism in the Adolescent Brain
21/03/2024
World’s first legal exporters of psilocybin solidifies partnership with acclaimed university in Canada for preclinical studies RUNAWAY BAY, Jamaica, March 21, 2024 (GLOBE NEWSWIRE) -- Rose Hill (or the “Company”), a [...]
Dyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, California
21/03/2024
JUPITER, Fla., March 21, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms to address the [...]
Capricor Therapeutics to Present at Upcoming Investor Conferences
21/03/2024
SAN DIEGO, March 21, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment and prevention of rare diseases [...]
Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler
21/03/2024
New Program Targets Estimated $2.5 Billion Eye Pain Market FREEHOLD, N.J., March 21, 2024 (GLOBE NEWSWIRE) -- Chromocell Therapeutics Corp. (“Chromocell”, or the “Company”), (NYSE American: CHRO), a pioneer in the [...]
Smart for Life Appoints Nutraceutical Industry Veteran Heather Granato to the Company’s Advisory Board
21/03/2024
Founder of Women In Nutraceuticals (WIN), Former VP of Numerous Industry Media Brands, and 30-Year Veteran of the Nutraceutical Industry Joins Highly Diversified Team of Advisors MIAMI, March 21, 2024 (GLOBE NEWSWIRE [...]
AiBtl BioPharma Inc. Completes $7.6M Land Deal: Exchanging Stock for Real Estate, Demonstrating the Value of ABVC's 23M AiBtl Share Ownership as Hundred Million Dollars
21/03/2024
FREMONT, CA, March 21, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in Oncology/Hematology, [...]
USDA-APHIS Determines that Yield10 Bioscience’s Omega-3 Camelina Varieties May Be Planted and Bred in the United States
21/03/2024
-Yield10 achieves significant milestone enabling ramp-up to commercial scale production of omega-3 fatty acids in Camelina -Omega-3 Camelina potentially represents a novel solution to the market need for omega-3 oils [...]
Landos Biopharma Provides Business Update and Reports Fourth Quarter and Full Year 2023 Results
21/03/2024
Top-line Results from the NEXUS Phase 2 Clinical Trial of NX-13 for Ulcerative Colitis Planned for Q4 2024 Sufficient Cash to Fund Planned Operations into mid-2025 NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- Landos [...]

Pages